The case for maintaining current regulations on I-131 therapy

Thursday, May 5, 2011 - 13:00 in Health & Medicine

Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer, known as I-131. Currently, the NRC recommends outpatient treatment for patients receiving radioactive iodine after total or near-total thyroidectomy; however, several groups have been urging NRC to mandate overnight hospital stays to protect others from a perceived risk of radiation exposure.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net